carteolol has been researched along with Choroid Neovascularization in 1 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ishida, S | 1 |
| Mochimaru, H | 1 |
| Nagai, N | 1 |
| Noda, K | 1 |
| Ozawa, Y | 1 |
1 other study available for carteolol and Choroid Neovascularization
| Article | Year |
|---|---|
[Effects of carteolol hydrochloride on experimental choroidal neovascularization].
Topics: Adrenergic beta-Antagonists; Animals; Carteolol; Choroidal Neovascularization; Mice; Mice, Inbred C5 | 2011 |